Effectiveness, Tolerability, and Safety of Mepolizumab Injection Spacing in Patients With Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Cohort Study
Our findings suggest that mepolizumab injection spacing is a well-tolerated treatment strategy for stable EGPA. It may be a viable and safe treatment option for the long-term use of biological agents for EGPA.
Authors
- Masahiro Ayano (ORCID: https://orcid.org/0000-0002-2954-9676)
- Motoki Yoshimura
- Yasushi Inoue (ORCID: https://orcid.org/0000-0002-8313-3591)
- Keisuke Nishimura (ORCID: https://orcid.org/0000-0002-5100-9166)
- J. Saegusa
- Yasutaka Kimoto (ORCID: https://orcid.org/0000-0002-0158-2917)
- Hiroaki Niiro (ORCID: https://orcid.org/0000-0003-0914-9066)
- Naoya Nishimura
Institutions
- Kyushu University (JP)
- Japanese Red Cross Fukuoka Hospital (JP)
- Kobe University (JP)
Publication Details
- Journal
- JCR Journal of Clinical Rheumatology
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1097/rhu.0000000000002321
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.00